Literature DB >> 16086124

Aggressive G-CSF-producing gastric cancer complicated by lung and brain abscesses, mimicking metastases.

Taku Yokoyama1, Masanobu Hyodo, Yoshinori Hosoya, Koji Koinuma, Kentarou Kurashina, Shin Saitoh, Yuuki Hirashima, Wataru Arai, Toru Zuiki, Yoshikazu Yasuda, Hideo Nagai, Nobuyuki Kanai, Ken Saitoh.   

Abstract

A 57-year-old Japanese man had type II c gastric cancer with marked lymph node metastases associated with leukocytosis and elevated granulocyte colony-stimulating factor (G-CSF). Total gastrectomy and distal pancreatectomy with lymph node dissection were performed. Although the primary lesion was negative for G-CSF by histopathological immunostaining, a highly increased G-CSF m-RNA level, measured using reverse transcriptase-polymerase chain reaction in frozen sections, led to a diagnosis of G-CSF-producing gastric cancer. The leukocytes and G-CSF decreased immediately after surgery. He then had an intraabdominal recurrence, and was diagnosed with multiple tumors in his lung and brain, with abnormally elevated leukocytes and greatly increased G-CSF; he died 4 months after the surgery. Autopsy showed intraabdominal recurrence of cancer, with no metastases to the lung or brain, but with multiple brain and lung abscesses. We speculate that the excessively increased neutrophils induced by G-CSF infiltrated the lung and brain and formed abscesses, mimicking metastases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086124     DOI: 10.1007/s10120-005-0335-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  12 in total

1.  The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression.

Authors:  L Overbergh; A Giulietti; D Valckx; R Decallonne; R Bouillon; C Mathieu
Journal:  J Biomol Tech       Date:  2003-03

2.  Glioblastoma causing granulocytosis by secretion of granulocyte-colony-stimulating factor.

Authors:  R Q Hintzen; J Voormolen; P Sonneveld; S G van Duinen
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

Review 3.  Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications.

Authors:  K Spiekermann; J Roesler; A Emmendoerffer; J Elsner; K Welte
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

4.  Establishment of specific monoclonal antibodies against recombinant human granulocyte colony-stimulating factor (hG-CSF) and their application for immunoperoxidase staining of paraffin-embedded sections.

Authors:  K Shimamura; J Fujimoto; J Hata; A Akatsuka; Y Ueyama; T Watanabe; N Tamaoki
Journal:  J Histochem Cytochem       Date:  1990-02       Impact factor: 2.479

5.  Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment.

Authors:  H J Ross; L A Moy; R Kaplan; R A Figlin
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

6.  Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.

Authors:  W Hilbe; W Nussbaumer; H Bonatti; J Thaler; D Niederwieser; D Nachbaur
Journal:  Bone Marrow Transplant       Date:  2000-10       Impact factor: 5.483

7.  Japanese Classification of Gastric Carcinoma - 2nd English Edition -

Authors: 
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

8.  Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF.

Authors:  M Baba; H Hasegawa; M Nakayabu; N Shimizu; S Suzuki; N Kamada; K Tani
Journal:  Am J Hematol       Date:  1995-07       Impact factor: 10.047

9.  A case of gastric carcinoma associated with excessive granulocytosis. Production of a colony-stimulating factor by the tumor.

Authors:  T Obara; Y Ito; T Kodama; Y Fujimoto; H Mizoguchi; K Oshimi; M Takahashi; A Hirayama
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

10.  Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer.

Authors:  W Koizumi; S Tanabe; K Saigenji; A Ohtsu; N Boku; F Nagashima; K Shirao; Y Matsumura; M Gotoh
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

View more
  9 in total

Review 1.  Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.

Authors:  Masahiko Kawaguchi; Yasuyuki Asada; Takuro Terada; Akira Takehara; Yoshinori Munemoto; Katsunori Fujisawa; Takeshi Mitsui; Yoshiro Iida; Shoji Miura; Yoshiko Sudo
Journal:  Int J Clin Oncol       Date:  2010-02-24       Impact factor: 3.402

Review 2.  Genetics of antipsychotic-induced side effects and agranulocytosis.

Authors:  Nabilah I Chowdhury; Gary Remington; James L Kennedy
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

3.  Granulocyte-colony-stimulating factor-producing gastric metastasis from large cell type lung cancer.

Authors:  Yasuo Yoshinaga; Hirokazu Kiyozaki; Shinichiro Okada; Fumio Konishi; Shigeki Yamada
Journal:  Clin J Gastroenterol       Date:  2010-12-15

4.  Rapid progression of a granulocyte colony-stimulating factor-producing liver tumor metastasized from esophagogastric junction cancer: A case report and literature review.

Authors:  Sojun Hoshimoto; Nobuo Hoshi; Iwao Ozawa; Moriaki Tomikawa; Hirofumi Shirakawa; Takeshi Fujita; Saho Wakamatsu; Sayuri Hoshi; Kaoru Hirabayashi; Shoichi Hishinuma; Yoshiro Ogata
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

5.  G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration.

Authors:  K T Morris; H Khan; A Ahmad; L L Weston; R A Nofchissey; I V Pinchuk; E J Beswick
Journal:  Br J Cancer       Date:  2014-01-21       Impact factor: 7.640

6.  Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses.

Authors:  Katherine T Morris; Eliseo F Castillo; Anita L Ray; Lea L Weston; Robert A Nofchissey; Joshua A Hanson; Von G Samedi; Irina V Pinchuk; Laurie G Hudson; Ellen J Beswick
Journal:  Oncotarget       Date:  2015-09-08

7.  G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers.

Authors:  Wenbin Li; Xinghua Zhang; Yongkang Chen; Yibin Xie; Jiancheng Liu; Qiang Feng; Yi Wang; Wei Yuan; Jie Ma
Journal:  Protein Cell       Date:  2016-01-21       Impact factor: 14.870

8.  Supplementary granulocyte macrophage colony-stimulating factor to chemotherapy and programmed death-ligand 1 blockade decreases local recurrence after surgery in bladder cancer.

Authors:  Makito Miyake; Shunta Hori; Sayuri Ohnishi; Michihiro Toritsuka; Tomomi Fujii; Takuto Shimizu; Takuya Owari; Yosuke Morizawa; Daisuke Gotoh; Yoshitaka Itami; Yasushi Nakai; Satoshi Anai; Kazumasa Torimoto; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Cancer Sci       Date:  2019-08-19       Impact factor: 6.716

9.  Genomic analysis of the prognostic value of colony-stimulating factors (CSFs) and colony-stimulating factor receptors (CSFRs) across 24 solid cancer types.

Authors:  Xinyi Huang; Pingping Hu; Jiandong Zhang
Journal:  Ann Transl Med       Date:  2020-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.